Tokyo, Sept. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057976) titled 'Communication About the Disclosure of Hereditary Cancer to Children: A Scoping Review Protocol' on Sept. 16.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Niigata University
Condition:
Condition - Hereditary Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to comprehensively review the current state of communication regarding the disclosure of hereditary tumors between parents and children, and to provide insights that will serve as a guide for future research on supportive approaches.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 18
years-old
>
Gender - Male and Female
Key inclusion criteria - Inclusion Criteria
1)Studies related to communication and support regarding the disclosure of hereditary tumors to children will be included.
2)No restrictions will be placed on study design.
3)Studies written in English or languages that the authors can accurately review will be included.
4)Relevant literature will be manually searched, and all non-duplicated studies meeting the criteria will be included in this scoping review.
Key exclusion criteria - 1)Studies for which only the title and abstract are available, and the full text cannot be accessed, will be excluded.
2)Studies including data from participants aged 18 years or older will be excluded if 20% or more of the participants are 18 years old or above.
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 04 Month 01 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2026 Year 01 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066281
Disclaimer: Curated by HT Syndication.
